Patients are getting surgeries again, says J&J
Johnson & Johnson JNJ, +0.10% said surgical procedure volumes are returning to pre-pandemic levels in…
Read MoreJohnson & Johnson JNJ, +0.10% said surgical procedure volumes are returning to pre-pandemic levels in…
Read MoreIs the billion-dollar COVID-19 testing sales boom over? That’s what Abbott Laboratories ABT, -6.42% is…
Read MoreU.S. stock indexes were mixed after erasing early losses Wednesday morning, as investors welcomed Netflix’s…
Read MoreAbbott Laboratories ABT, -1.55% is focused on recovering its position in the baby-formula market in…
Read More